Save 40% on Standard Digital was $540 now $319 for your first year Save now on essential digital access to quality FT journalism on any device. Saving based on monthly annualised price. Go to Source
Tag: Possible_Terrorism_Warfare
Is BYD Co. About to Leave Tesla in the Dust?
Tesla put up a fight and unleashed a strong third-quarter delivery result, but BYD might continue speeding ahead for the rest of 2025. It’s been a pretty wild roller-coaster ride for Tesla (TSLA 2.97%) investors in 2025. The company has dealt with a plethora of developments, both bad and good, sending its share price plunging… Continue reading Is BYD Co. About to Leave Tesla in the Dust?
Parasitic Startup Pollutes Job Market by Applying to Jobs for You Automatically
Getty / Futurism Look, it’s a hard job market out there. Not only has new job creation slowed to a drip, but the positions that do exist are increasingly hidden behind labyrinthian AI screening software and bizarre HR scams. Not to worry, because a new startup is rising to help job seekers brute force their… Continue reading Parasitic Startup Pollutes Job Market by Applying to Jobs for You Automatically
CUMBERLAND PHARMACEUTICALS’ VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC.
Premier Membership includes 4,350 U.S. Hospitals NASHVILLE, Tenn., Oct. 13, 2025 /PRNewswire/ — Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, has added their potent antibiotic, Vibativ® (telavancin), to a national group purchasing agreement with Premier, Inc. Effective October 1, 2025 the product addition allows Premier members, at their discretion, to take advantage of… Continue reading CUMBERLAND PHARMACEUTICALS’ VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC.
Digital Privacy Tools (2025): How Avast Helps Consumers Stay Safe While Browsing and Shopping Online – Report by Better Business Advice
NEW YORK, Oct. 13, 2025 /PRNewswire/ — As digital life becomes more complex, consumers face heightened risks when browsing the web, shopping online, and managing personal information. A new report by Better Business Advice examines how Avast, a longstanding cybersecurity provider, structures its privacy tools to help individuals safeguard sensitive data against tracking, breaches, and… Continue reading Digital Privacy Tools (2025): How Avast Helps Consumers Stay Safe While Browsing and Shopping Online – Report by Better Business Advice
Has Cadillac ever succeeded in the UK?
Enjoy full access to the complete Autocar archive at the magazineshop.com In 1927, GM transferred the UK Cadillac concession to Lendrum & Hartman, which opened a grand showroom in Mayfair, where the Type V-63 would be sold alongside GM’s lesser La Salle and Buick cars. Two years later, Cadillac made another engineering innovation: a V16… Continue reading Has Cadillac ever succeeded in the UK?
Will the Long-Range Model Y+ Help Tesla Catch Up in China?
Once the undisputed electric vehicle (EV) leader in the world’s largest EV market, Tesla TSLA is now under pressure from homegrown rivals. As competition intensifies and price wars deepen, Tesla is hoping that its new variant— the Model Y+ — can ignite buyer interest and help it regain lost ground. Per CnEVPost, Tesla China sold… Continue reading Will the Long-Range Model Y+ Help Tesla Catch Up in China?
Third Indication for Kelun-Biotech’s TROP2 ADC Sac-TMT Approved for Marketing by NMPA in EGFRm NSCLC Following Progression on EGFR-TKI Therapy
CHENGDU, China, Oct. 11, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that the Company’s trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) was approved for marketing by the National Medical Products Administration (NMPA) for its third indication, the treatment of adult patients with epidermal growth factor receptor (EGFR) mutant-positive locally advanced… Continue reading Third Indication for Kelun-Biotech’s TROP2 ADC Sac-TMT Approved for Marketing by NMPA in EGFRm NSCLC Following Progression on EGFR-TKI Therapy
Government Investigating Nearly Three Million Self-Driving Teslas for Violating Traffic Laws, Crashing
Illustration by Tag Hartman-Simkins / Futurism. Source: Visual China Group via Getty Images/Visual China Group via Getty Images Is it a good sign that Tesla keeps getting probed by regulators because its self-driving cars are horrible drivers? You’ll never guess the reason we’re asking. On Thursday, the US National Highway Traffic Safety Administration said it’s… Continue reading Government Investigating Nearly Three Million Self-Driving Teslas for Violating Traffic Laws, Crashing
WIRED Roundup: Are We In An AI Bubble?
Zoë Schiffer: Our first story this week is about Mark Bray. He is a professor at Rutgers University and he wrote a book almost a decade ago about antifa, and he’s currently trying to flee the United States for Europe. This comes after an online campaign against him led by far-right influencers eventually escalated into… Continue reading WIRED Roundup: Are We In An AI Bubble?